congeneric series
Picture a family photo where everyone has the same nose and jaw but different haircuts. A congeneric series is a family of molecules built on one shared core, where the members differ only by what is swapped onto a few defined positions. They are recognizably the same kind of compound, varied in the details.
Technically, a congeneric series is a set of compounds that share a common scaffold and a common mechanism of binding, differing by changes at one or a small number of substituent positions. Because the constant core holds the binding mode roughly fixed, differences in measured activity can be attributed mainly to the substituent changes rather than to a wholesale change in how the molecule sits in the pocket — making the series a clean experiment for reading SAR.
Series-based thinking is how most lead optimization is organized, and methods like Free–Wilson analysis explicitly assume a congeneric series. The caveat is that the assumption of a conserved binding mode can quietly break: a bulky or charged substituent may flip the molecule into a new pose, after which comparisons across the series no longer mean what they seem to.
Twenty analogs of a single benzamide lead, each carrying a different group at the same para position, form a congeneric series in which potency can be plotted directly against that one substituent's properties.
Holding the scaffold constant isolates the effect of each substituent change.
Congeneric means sharing the same scaffold and binding mode. A set of structurally diverse compounds hitting the same target is a chemotype-diverse set, not a congeneric series, and is analyzed differently.